Skip to main content

Primary Refractory Lymphoma

Non Hodgkin Lymphoma NHL
Non Hodgkins Lymphoma Overviews

Treatment of Relapsed/Refractory Aggressive Non Hodgkins Lymphoma

Dec 14, 2021
Image placeholder title
Non Hodgkins Lymphoma Treatment

FDA Approves Kymriah for Treatment of Relapsed or Refractory (DLBCL)

Aug 28, 2021